11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Veristat Announces Participation in the "Triangle Perspective on AI, ML, & the Future of Drug Development" Panel Discussion
Veristat is excited to announce that our Chief Commercial Officer, Rachel Page, will be a panelist in the upcoming event organized by Sterling Bay, "Triangle Perspective on AI, ML, & the Future of Drug Development." This engaging panel discussion will feature five leading life sciences executives and two highly accomplished moderators examining the transformative impact of artificial intelligence (AI) and machine learning (ML) on the future of drug development.
Event Details:
Date and Time: Wednesday, July 17, 2024, 9:00 AM to 9:50 AM ET USA
Format: Webinar via Zoom (Zoom link will be distributed prior to the webinar. The session will be recorded and made available for those unable to attend live.)
Registration: Register Here
Panel Discussion Highlights:
The panel will focus on how AI/ML developments are revolutionizing the global biopharmaceutical industry, with a particular emphasis on the life sciences sector in North Carolina and the Research Triangle. Topics covered will include drug discovery, development, and deployment.
Panelists:
Rachel Page, Chief Commercial Officer, Veristat
Joe Webb, Chief Executive Officer & Founder, Vitality Robotics
Julie Blasingim, Chief Executive Officer, Univo IRB
Mark Sydnor, President, Network Partners Group
Robin Hyde-DeRuyscher, President and Chief Scientific Officer, Emergo Therapeutics
Co-Moderators:
Kate Pestrichelli, Vice President, Program Management, Network Partners Group Stephanie Gaulding, Managing Director, Pharmatech Associates, a USP company
MC:
Michael Daniel, MSChE, Product Development Consultant, Pharma & CG Industries
Join Us:
Don't miss this opportunity to gain insights from industry leaders about the future of drug development in the age of AI and ML. We encourage you to register and invite others to attend this informative session.
We look forward to seeing you there and sharing how Veristat is contributing to advancements in the life sciences industry.
Registration: Register Here
Schedule A Meeting
Interested in meeting with Rachael Page, Chief Commercial Officer at Veristat, Complete the form below
Event Topics:
2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...